To interrogate the in vivo persistence of CAR T cell variants, NSG mice were engrafted subcutaneously (s.c.)with IL13Rα2-expressing M202 melanoma cells followed by IT treatment with CAR T cell variants that coexpress ffLuc. The gene discussed is IL13RA2; the disease is melanoma.